Geber Science
Fostering the growth of early-stage companies in healthcare, bioinformatics, and drug discovery
Geber Science
Fostering the growth of early-stage companies in healthcare, bioinformatics, and drug discovery
From Series A to Clinical Trials
Since the time that alchemists put stylus to papyrus, people in the chemical sciences have written down descriptions of their observations and findings. The wide availability of easily accessible computing power combined with the prolific amounts of data generated through scientific experiments, has leveled the playing field for small organizations to leverage that knowledge and change drug discovery for all.
Computational Drug Discovery
Harnessing Big Data to deliver the next therapeutic success
Computational Drug Discovery
Harnessing Big Data to deliver the next therapeutic success
Geber Science works with early-stage drug discovery organizations across all stages of growth -- from the first idea, to building the founding team, product launch and exit.
Our customers and partners are a select group of computer scientists, medicinal chemists and biologists, and entrepreneurs focused on the development of scientific platforms for drug discovery, early screening, and in silico toxicology.
While science has always focused on new ways to develop and capture information, our partner companies have focused on information retrieval and analysis.
The drug discovery and pharmaceutical realm sits on a wealth of experimental and in-vitro data to detect, assess, and value new and existing therapeutic compounds - we focus on innovative platforms that help partners to leverage that information.
Advancing Biological Sciences
Partnering with early-stage teams
Advancing Biological Sciences
Partnering with early-stage teams
BioInformatics
OPERATIONAL RIGOR
From discovery in vitro or discovery in-silico -- the application of data management tools and principles to generate breakthrough therapies and rediscover the value within a portfolio of compounds.
Product Development
PRELAUNCH TO IPO
Helping good products become great - at the intersection of life sciences and computer science. Guiding teams through early-stage regulatory, scientific, operational and business challenges. Building on more than thirty years of experience within the scientific, operational, and financial realm.
Drug Discovery
SCIENTIFIC ADVISORY
From small molecules to biologicals. We assist in the development or repurposing of novel or existing therapeutic compounds.